Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

The risk for moderate to severe infection in later childhood was associated with overall infection burden in early life.

A group of former US CDC employees is fighting to get their jobs back after being abruptly laid off last month.

The risk for pediatric asthma is greater among children who, as newborns, received antibiotic therapy due to a maternal indication.

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

COVID-19 vaccination in early pregnancy (≤20 weeks gestation) is not associated with increased prevalence of major structural birth defects.

“The free at-home COVID-19 test distribution program is not currently accepting orders,” the website states. However, tests that were ordered before 8 p.m. ET on March 9 will still be shipped.

American Society of Regional Anesthesia and Pain Medicine guidelines highlight SSI prevention in regional anesthesia and ...

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

The NIH is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.